Research
White blood cell counts higher among CRAO patients
Higher systemic leukocyte and lymphocyte levels point to subtype-specific inflammatory profiles.
Legal
Vermont passes bill authorizing optometric laser procedures
Effective in 2028, legislation permits several in-office ophthalmic laser surgeries—plus establishes training, education, and State Board requirements.
Products
ZEISS and Envision Health Technologies partner on VR functional testing for glaucoma
Strategic collaboration utilizes Envision's gamified, virtual-reality-based immersive visual field testing with ZEISS's perimetry expertise.
Products
Saptalis launches cyclosporine 0.05% generic amid portfolio expansion
Generic of Allergan’s Restasis is indicated to increase tear production, targeting inflammation as an underlying cause of dry eye.
Research
Glaucoma risk higher among women with postmenopausal HRT
Postmenopausal hormone therapy may be linked to higher glaucoma risk, with registry data suggesting the association holds across hormone types.
Pipeline
FDA accepts Outlook's fourth wet AMD BLA submission
The latest BLA package of ONS-5010 / LYTENAVA (bevacizumab-vikg) has received a PDUFA target action date for late July.
Products
OCuSOFT launches Retaine Ultra PF in a multi-dose bottle
Marketed as a daily, multi-dose lubricant eye drop, this new addition offers fact-acting hydration and a “moisture-rich” formulation for sensitive eyes.
Research
US uveitis workforce projected to decline 35% by 2055
Products
FDA clears Euclid's Be Free Day multifocal toric contact lens
New SiHy lens offers myopia / astigmatism management with a patented dual-action, multi-step optical design technology for presbyopia correction.
Events
Optometry's Meeting 2026: Show floor highlights and key industry takeaways
The AOA and AOSA’s annual meeting saw its highest attendance record in years as thousands flocked to Phoenix, Arizona.
Products
Alcon introduces expanded parameters across toric contact lens portfolio
Updated ranges apply to its WaterInnovations astigmatism lens portfolio: PRECISION1, PRECISION7, and TOTAL30.
Events
The Myopia Collective adds Student Change Agent advocates to nationwide initiative
Students from the nation's top optometry school join a new cohort of Change Agents as TMC hosts first-ever Day of Advocacy during Optometry's Meeting.
Products
Johnson & Johnson to launch expanded parameters for ACUVUE OASYS 1-Day for Astigmatism
Daily lens infused with HydraLuxe Technology will now expand to –2.75 cylinder to offer coverage for up to a reported 89% of astigmatic eyes.
Research
Aquatic virus linked to new human eye disease
Covert mortality nodavirus, a pathogen of farmed shrimp and fish, presented in the eye tissue of patients with a vision-threatening uveitis emerging in China.
Pipeline
Ethyreal Bio debuts with $101M in funding to advance TED therapy
Biotech company emerges from stealth with Series B financing supporting FIH trial initiation for ETHY-001, an anti-TSHR antibody for TED and Graves’ disease.
Pipeline
Belite Bio completes rolling NDA submission of oral tinlarebant for Stargardt
Next up: a 60-day review period ahead of a potential PDUFA target action date assignment; could become the first FDA-approved treatment for Stargardt.
Products
Thea Pharma's ZOLYMBUS ophthalmic gel launches for glaucoma management
The PF formulation debuts 9 months after securing FDA approval with a patented mucoadhesive lubricating gel technology for IOP reduction.
Pipeline
Dompé kicks off patient dosing in phase 3 PCED trial on cenegermin-bkbj
Phase 3 ORUNEA trial is assessing whether targeting the biological drivers of epithelial repair can improve healing in PCED.
Products
Johnson & Johnson expands US rollout of TECNIS PureSee IOL
The FDA-cleared, extended-depth-of-focus lens is the first of its kind with no warning on loss of contrast sensitivity.
Research